European Formula Guides

Baby Formula Trends 2027: What’s Coming Next in Infant Nutrition

ErikaReviewed by the OLS parent-proofing process — reputable sources & pediatric insights
Baby Formula Trends 2027: What’s Coming Next in Infant Nutrition

2027 looks like a turning point for many parents choosing a formula. HMO formulas, made with human milk oligosaccharides, are already available, and the growing market for A2 protein is giving parents more options.

Baby formula trends 2027 bring a wave of innovation, with Kendamil, Holle, HiPP, ByHeart, Bobbie, and a few new European players leading the way. Every year, more ingredients and brands reach the US market, and new formula ingredients are designed to match a baby’s body more closely.

The Big 2027 Ingredient Trends: What’s Expanding Across the Industry

Stricter infant formula standards are being researched, and 2026 was a year of ingredient change. New formula ingredients closer to breast milk, such as HMOs and lactoferrin, are spreading, along with A2 protein and hydrolyzed options. Three forces drive these trends: scientific research, consumer demand for premium products, and competition between brands.

Ingredient

2026 Status

2027 Expected

HMO (human milk oligosaccharides)

2’-FL in most premium formulas; some adding 5-6 HMO blends

Multi-HMO blends becoming standard in premium formulas; declining costs and wider brand adoption

Lactoferrin

Included in Kendamil and some ByHeart products; available in select premium formulas

Expected to become standard in European premium formulas, with growing US premium adoption

A2 protein

Niche ingredient (Kabrita goat A2; a2 Milk Company toddler products)

Expected mainstream expansion; Kendamil and others exploring A2 cow milk sources

MFGM (milk fat globule membrane)

Naturally present in Kendamil whole milk; added to some Enfamil formulas

Wider inclusion, with clearer distinctions between naturally occurring and added MFGM

Prebiotics (GOS/FOS) + probiotics

Standard in European Combiotic lines, including HiPP

Continued standard use and wider bacterial strain diversity

Heavy metal + contaminant reduction

EFSA cereulide standards tightening in early 2026

Continued stricter global standards, with the EU leading regulatory developments

Baby formula innovation is drawing a lot of parental attention. European brands are entering the US with advanced formulas, and the US market is responding with new premium lines from Enfamil and Similac. Not every ingredient trend is justified, since some are driven by marketing. Still, baby formula trends in 2027 are shaped by DHA, MFGM, HMOs, and lactoferrin, and parents are watching them closely.

HMO Expansion and Lactoferrin: Why Premium Formulas Are Getting Closer to Breast Milk

HMO formula trends are moving fast because oligosaccharides are abundant in breast milk. They feed beneficial gut bacteria, help protect against pathogens, and support brain development. Breast milk contains over 150 different HMOs, while formulas today use one to six synthetic ones.

  • 2026 HMO landscape. Some premium formulas already contain five to six HMOs, and clinical formulas and European brands are increasingly adding them too.

  • 2027 HMO prediction. HMO formula trends point to widespread multi-HMO formulas, as production costs fall with scale.

  • Lactoferrin. This iron-binding protein occurs naturally in human colostrum. It supports immune system development, iron metabolism, and gut protection.

  • 2027 lactoferrin prediction. Lactoferrin formula is expected to appear in European premium lines such as Kendamil, HiPP, Holle, and Lebenswert, as well as in premium US brands (Bobbie is investigating; ByHeart is continuing).

Formulas that combine multi-HMO, lactoferrin, MFGM, and DHA come closest to breast milk. Their ingredients are largely backed by research and aren’t just a marketing ploy. Adding multi-HMO and lactoferrin costs roughly $5-10 more per can.

A2 Protein Going Mainstream and the Rise of Personalized Formula

A2 protein formula trends are picking up speed. Beta-casein in cow’s milk comes in two main variants, A1 and A2. Standard cow’s milk contains both, while A2 milk comes from cows with a specific genetic variant. Some evidence suggests A2 is gentler for babies with mild cow’s milk sensitivity.

In 2026, Kabrita goat milk is naturally A2-dominant, and the A2 Milk Company sells A2 toddler products in the US; few infant formulas use A2 cow’s milk. For 2027, Kendamil and Holle are both investigating sources of A2 cow’s milk, and growing demand is pushing manufacturers to build supply chains for it. Several A2 cow’s milk formulas are expected to reach the market, and these A2 protein formula trends will matter most to families dealing with mild sensitivity.

Personalized baby formula is the other side of 2027. It suits infants with mild cow’s milk sensitivity, while cow’s milk protein allergy (CMPA) calls for an extensively hydrolyzed (EHF) or amino acid-based (AAF) formula chosen with a pediatrician. Recommendations are getting more tailored to the baby, though consumer microbiome testing is still in its infancy. Companies such as Tiny Health already offer infant microbiome testing.

Microbiome formula should become more popular in 2027. Parents may soon get a more precise formula match based on the baby’s digestion, family history, and special needs. Organic Life Start (OLS) keeps adding options as personalization grows.

New formula ingredients shaping infant nutrition

Sustainability, Regulations, and the Changing Formula Supply Chain

Baby formula regulation 2027 is worth a look for every parent. European brands lead: Kendamil is investigating carbon-neutral production, Holle’s biodynamic farming and Demeter certification are popular with parents, and HiPP’s long-term organic and ecological commitment attracts families too. Sustainable baby formula packaging is improving as well: tins and aluminum cans are becoming easier to recycle, and brands are testing less cardboard, bioplastic alternatives, and lower carbon claims.

  • EU rules: EFSA’s 2026 cereulide guidance (maximum residue 0.43 ng/g) sets stricter contamination limits, and rules on pesticide residues, GMO contamination, allergen labeling, and traceability of imported ingredients are tightening

  • FDA status: since 2022, the FDA has allowed foreign formulas to be imported under enforcement discretion, which is why many European formulas are sold in the US

  • Full approval: the future of infant formula for 2027 includes full FDA approval for most of these products, and some may lose their status if manufacturers don’t apply; OLS carries only legally available products

  • New brands: Löwenzahn (Germany, early stage) and Loulouka (Switzerland, limited US quantities) are entering the US, and more European brands are expected in US retail

  • 2022 impact: the Abbott Sturgis plant is back up and running

  • Sales channels: baby formula trends 2027 also affect how formula is sold, through importers (OLS), direct sales, and Target and Amazon retail

Price Trend Predictions and What OLS Is Stocking for 2027

New formula brands in 2027 keep surprising parents, and now is a good time to review price forecasts and what OLS plans to carry. Inflation, supply chain problems, and premium ingredients are expected to push prices in the premium category up by 5-10%.

Brand

2026 OLS Status

2027 Expected

Kendamil

Full range (Classic, Organic, Goat, Comfort) in powder and RTF formats

Expanded RTF lineup, potential A2 cow milk product, continued core range expansion

HiPP

Full range (Combiotic Dutch, German, UK; HA; Comfort; AR; Goat)

Expected multi-HMO additions to Combiotic lines and continued stage expansion

Holle

Full range (Bio, Goat)

Potential additional stages and variants, plus sustainability-focused packaging improvements

Kabrita

Full goat milk range

Potential new stages and A2 cow milk addition

New Brands 2027

Löwenzahn (Germany), continued Lebenswert expansion, potential new Swiss or Austrian additions

Added as regulatory clearance and import availability allow

The future of infant formula looks promising for parents, and subscriptions and ongoing discounts may offset most of the price increases. New additions need careful vetting, from regulatory status to taste testing. New formula brands in 2027 have to match the quality of what’s already on the shelf.

Which Current Formula Should You Stock Up on Before 2027 Changes?

New formula ingredients should improve composition and move closer to breast milk. If your baby is doing well on the current formula, there’s no reason to switch to a 2027 trend. Replace it if it lacks DHA and ARA. If your baby has digestive sensitivity, you can talk to your pediatrician about a formula with HMOs and lactoferrin. For mild to moderate cow’s milk sensitivity, ask about A2 or goat options.

  • Expectations: the future of infant formula brings richer ingredient profiles more often, starting in 2027

  • Inventory: if your current formula has a shelf life of 18-24 months, a bulk purchase on Black Friday 2026 is an option

  • Transition formulas: brands with several variants, such as Kendamil Classic, Organic, and Goat, or HiPP Combiotic, HA, Comfort, and AR, let you adjust without changing brands completely

  • OLS pre-order: new products are often available for pre-order several months before launch

  • Stability: keep one or two fully reliable formulas as a base and add other variants when needed

  • Pediatrician: lactoferrin formula needs a pediatrician’s input, especially before switching between variants; stay in contact with your pediatrician for A2 and hypoallergenic options

FAQ + Final Thoughts: Preparing for 2027 Infant Nutrition Landscape
Should I switch formulas to get 2027 ingredient improvements?
If your baby's current formula suits them, keep it. For digestive problems or special needs, talk to your pediatrician about formulas with HMOs, lactoferrin, and MFGM.
When will more European formulas be FDA-approved?
Kendamil (March 2024) and Kabrita (2024) are listed as pending with the FDA. Several more European brands are expected to receive full approval in 2027.
Will formula prices really go up 5-10% in 2027?
Prices will likely rise because of inflation, ingredient costs, and supply-chain issues. Subscriptions can soften the increase.
Is personalized formula actually available in 2027?
Personalized baby formula will come with better recommendations, such as AI matching and microbiome testing. These tools can support formula choice, but they don't replace a pediatrician's advice.
What's the single biggest 2027 formula trend parents should know?
The expansion of HMOs and lactoferrin, which gives more formulas an ingredient profile close to breast milk.
Is OLS adding new brands in 2027?
Yes. Additions are planned depending on FDA approvals and import availability.

Baby formula innovation is bringing real changes: ingredients closer to breast milk, A2 protein gaining ground, better personalization, and tighter regulation. You can find premium European infant formulas at Organic Life Start as the industry evolves.

Leave a comment

Your email address will not be published. Required fields are marked *

Please note, comments must be approved before they are published

Back to European Formula Guides